Metastatic spermatocytic seminoma - An extremely rare disease: Part 2

European Urology

Volumn 49, Issue 2, 2006, Pages 408-409

  Steiner, Hannes ^a   Gozzi, Christian ^a   Verdorfer, Irmgard ^a   Mikuz, Gregor ^a   Bartsch, Georg ^a   Hobisch, Alfred ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b General Hospital Feldkirch   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; TUMOR MARKER;

ARTICLE; BIOPSY; CANCER REGRESSION; CHEMOTHERAPY; FOLLOW UP; GERM CELL; HISTOLOGY; HUMAN; ORCHIECTOMY; PRIORITY JOURNAL; SEMINOMA; UNSPECIFIED SIDE EFFECT;

HUMANS; MALE; NEOPLASM STAGING; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 32044464097     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.12.044     Document Type: Article

References (3)

1. H. Stoop, R. van Gurp, R. de Krijger, A. Geurts van Kessel, B. Koberle, and W. Oosterhuis Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications Lab Invest 7 2001 919 928
2. E. Rajpert-De Meyts, G.K. Jacobsen, J. Bartkova, F. Aubry, M. Samson, and J. Bartek The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE- A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma Histopathology 3 2003 217 226
3. J. Matoska, D. Ondrus, and M. Hornak Metastatic spermatocytic seminoma. A case report with light microscopic, ultrastructural, and immunohistochemical findings Cancer 6 1988 1197 1201